| Vivimed Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532660 |
NSE Symbol : VIVIMEDLAB |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE526G01021 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 0.92 |
Market Cap(₹Cr) : 66.17 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 103.60 | 136.80 | 176.83 | 218.37 | 210.05 |
| Other Income | 4.19 | 9.57 | 0.24 | 1.26 | 6.08 |
| Stock Adjustments | 1.79 | 18.07 | -62.63 | -0.49 | -4.31 |
| Total Income | 109.58 | 164.44 | 114.44 | 219.14 | 211.82 |
| EXPENDITURE : | |||||
| Raw Materials | 60.12 | 85.39 | 206.00 | 142.92 | 92.76 |
| Power and Fuel Cost | 3.48 | 4.87 | 8.73 | 7.55 | 9.02 |
| Other Manufacturing Expenses | 6.22 | 10.26 | 19.42 | 17.65 | 18.98 |
| Selling and Administration Expenses | 27.03 | 25.87 | 37.65 | 26.70 | 30.76 |
| Miscellaneous Expenses | 0.00 | 32.17 | 0.63 | 0.42 | -0.07 |
| Employee Benefit Expenses | 23.04 | 29.45 | 29.67 | 31.68 | 26.45 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | -10.33 | -23.56 | -187.67 | -7.78 | 33.91 |
| Interest | 2.54 | 2.41 | 35.55 | 39.71 | 41.63 |
| Gross Profit | -12.87 | -25.97 | -223.22 | -47.49 | -7.72 |
| Depreciation | 18.63 | 18.41 | 106.91 | 17.45 | 15.80 |
| Profit Before Tax | -31.50 | -44.38 | -330.13 | -64.94 | -23.52 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | -2.12 | 2.82 | -0.23 |
| Reported Net Profit | -31.50 | -44.38 | -328.01 | -67.75 | -23.28 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | -31.50 | -44.38 | -328.01 | -67.75 | -23.28 |
| Adjustment below Net Profit | 0.58 | 0.48 | 4.05 | 0.56 | -6.14 |
| Profit/Loss Balance carried down | -160.33 | -116.42 | 207.54 | 274.73 | 304.15 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -191.25 | -160.33 | -116.42 | 207.54 | 274.73 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -3.80 | -5.35 | -39.56 | -8.17 | -2.81 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 2.47 | 6.20 | 11.50 | 50.57 | 58.67 |
| Book Value(Adj)-Unit Curr | - | - | 11.50 | 50.57 | 58.67 |